A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2004
12/23/2004	WO2004022004A3 Modified glp-1 receptor agonists and their pharmacological methods of use
12/23/2004	WO2004013294A3 Method of producing non-recombinant bmp-2 and use thereof
12/23/2004	WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/23/2004	WO2003106491A3 Cell penetrating peptides
12/23/2004	WO2003089002A9 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
12/23/2004	WO2003083436A3 Fibrinogen binding moieties
12/23/2004	WO2003077852A8 CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-β
12/23/2004	WO2003076584A3 Novel proteins and nucleic acids encoding same
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	WO2003072713A3 Use of bcma as an immunoregulatory agent
12/23/2004	WO2003052075A3 Enzymes
12/23/2004	WO2003050236A3 Human genes and gene expression products isolated from human prostate
12/23/2004	WO2003037167A3 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
12/23/2004	WO2002077013A3 Human secreted proteins
12/23/2004	US20040260268 Drug/drug delivery systems for the prevention and treatment of vascular disease
12/23/2004	US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis
12/23/2004	US20040260078 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
12/23/2004	US20040260069 Modified anti-tnf aplha antibody
12/23/2004	US20040260065 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo
12/23/2004	US20040260064 Monoclonal antibodies or fragments thereof which bind macrophage stimulating protein (MSP) analog comprising unpaired cysteine residue substituted with another amino acid, and which does not bind to wild-type MSP; for treatment of gastrointestinal and hematopoietic disorders
12/23/2004	US20040260063 Chimeric peptide: antagonist, endogeneous ligand binding to protein; therapy for metabolism disorders; obesity
12/23/2004	US20040260062 Stress-responsive activator of p300 (strap) protein
12/23/2004	US20040260060 Under control of tryptophan operon in prokaryotic host cell; gene overexpression due to point mutations, site-directed mutagenesis, or deletions;
12/23/2004	US20040259945 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
12/23/2004	US20040259942 Modulation of stat activity
12/23/2004	US20040259932 Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259886 Compositions and methods for treating osteoporosis and lowering cholesterol
12/23/2004	US20040259852 Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
12/23/2004	US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay
12/23/2004	US20040259828 Intravascular delivery of non-viral nucleic acid
12/23/2004	US20040259827 Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus Vpr protein
12/23/2004	US20040259824 Antisense modulation of cd40 ligand expression
12/23/2004	US20040259808 Captopril derivatives
12/23/2004	US20040259807 Monocyte locomotion inhibitory factor
12/23/2004	US20040259806 Treatment of tuberculosis using immunomodulator compounds
12/23/2004	US20040259805 Stimulant of milk ejection; contraction; stability
12/23/2004	US20040259803 Disease prevention by reactivation of the thymus
12/23/2004	US20040259802 Anti-chrondrosarcoma compounds
12/23/2004	US20040259801 Ion exchanging a peptide; then salt formation; therapy for benign prostate hyperplasia; endometriosis
12/23/2004	US20040259800 Apoptosis of rectum and prostate cancer
12/23/2004	US20040259798 Drugs; integrin antagonist; antiinflammatory agents; leukemia therapy
12/23/2004	US20040259796 Using a peptide
12/23/2004	US20040259795 Reducing sepsis; binding polypeptide to monoclonal antibody ; intensify gene expression; wound healing agents
12/23/2004	US20040259794 MuO-conopeptides and their use as local anesthetics
12/23/2004	US20040259793 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia
12/23/2004	US20040259792 Inhibitors of phosphodiesterases in infertility
12/23/2004	US20040259791 Methods of inducing apoptosis in hyperproliferative cells
12/23/2004	US20040259788 Use of neurotoxin therapy for treatment of urologic and related disorders
12/23/2004	US20040259787 C1q and collectin receptor
12/23/2004	US20040259785 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
12/23/2004	US20040259784 Compositions and methods for treatment of muscle pain and muscle wasting
12/23/2004	US20040259783 Pharmaceutical compositions of marine sponge microciona prolifera
12/23/2004	US20040259782 Structural formulas based on the repetitive motifs of salivary proline rich proteins mucin and collagen designed to modulate cell and tissue growth division and differentiation
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259780 Method for treating diabetes and obesity
12/23/2004	US20040259779 Novel neurotrophic factors
12/23/2004	US20040259778 Utilization of histamine receptor h3 gene participating in body weight or food intake control
12/23/2004	US20040259777 Method of treating metabolic disorders using neuronatin polypeptides
12/23/2004	US20040259776 Screening for apoptosis
12/23/2004	US20040259775 Receptor ligand; for opiods; analgesics, anxiolytic agents, drug abuse, cognition activators
12/23/2004	US20040259774 Nucleotide sequences; binding to antibodies
12/23/2004	US20040259773 Viricide peptide; nucleic acids encoding cyclic peptide
12/23/2004	US20040259772 Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell
12/23/2004	US20040259769 Hemoglobulin for oxygen delivery; cardiovascular disorders; gastrointestinal disorders
12/23/2004	US20040259768 Deactivable compound produced by target cell; diagnosis, therapy disease
12/23/2004	US20040259250 Methods and compositions for modifying a receptor tyrosine kinase protein tyrosine kinase signal to an apoptotic signal in a cell
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259245 Complete nutrient medium for use as a cosmetic and cosmetic use thereof
12/23/2004	US20040259220 CLK protein kinases and related products and methods
12/23/2004	US20040259202 Novel angiogenesis inhibitor
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259198 Methionine adenosyltransferase II (MAT II); hybridoma cell lines; transgenic animals; assay kits
12/23/2004	US20040259196 T cell receptor variants expressed in mesenchymal cells and uses thereof
12/23/2004	US20040259195 Anti-cellular proliferative disorder polypeptide
12/23/2004	US20040259193 using a polypeptide having JAB subunit or the JAM domain that confers isopeptidase activity to deconjugate a modifier protein from a target protein; e.g. de-ubiquitination; use in drug screening
12/23/2004	US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment
12/23/2004	US20040259176 facilitating death of cancer cells by inhibiting tissue transglutaminase; anticancer agent drug design using three-dimensional structure of a crystallized tissue transglutaminase
12/23/2004	US20040259171 P2Y4 antibody and methods of use
12/23/2004	US20040259159 Role of LDL receptor protein-1 (LRP-1) in Alzheimer's disease
12/23/2004	US20040259156 Bispecific immunoglobulin-like antigen binding proteins and method of production
12/23/2004	US20040259139 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
12/23/2004	US20040259136 diagnosis of arthritis based on elevated test amount of a zeta PKC gene product; drug screening, antisense agents and short interfering RNA (siRNA)
12/23/2004	US20040259126 MN gene and protein
12/23/2004	US20040259114 Coactivators in the diagnosis and treatment of breast cancer
12/23/2004	US20040259113 by determining the presence of kallikrein protein, hK2 polypeptide of hK2 RNA in a physiological sample
12/23/2004	US20040259110 Gene PRV-1 and its use
12/23/2004	US20040259097 Method for the in vitro synthesis of short double stranded rnas
12/23/2004	US20040259084 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
12/23/2004	US20040259074 Retinoid metabolizing protein
12/23/2004	US20040258779 A cytoprotective soy isoflavone and peptidoglycan of Lactobacillus Plantarum, N-acetyl-glucosamine-N-acetyl-muramyl-L-alanine-D-isoglutamine-meso-diaminopimelyl-D-alanine; antiapoptotic agents; humans and domesticated animals
12/23/2004	US20040258747 NGR(asparagine-glycine-arginine) molecule linked to encapsulating vehicle capable of delivering folds of antitumor agents comprising doxorubicin, vincristine, mitoxantrone, calicheamicin, Iressa, or Gleevec; anticarcinogenic agents; amino-polyethylene glycol phosphatidylethanolamine derivative liposomes
12/23/2004	US20040258745 Pharmaceutical composition containing artificial oxygen carrier
12/23/2004	US20040258715 Porcine circoviruses, vaccines and diagnostic reagents
12/23/2004	US20040258709 Hepatitis B virus polypeptides
12/23/2004	US20040258708 Cytotoxic T-cell epitopes of papillomavirus L1 protein and their use in diagnostics and therapy
12/23/2004	US20040258704 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/23/2004	US20040258699 Treating an animal infected with Bacillus anthracis by administering an antibody or antibody fragment having binding affinity to the protective antigen of Bacillus anthracis and the ability to block binding of the protective antigen to cell receptors, edema factor and lethal factor; vaccines
12/23/2004	US20040258695 Transferrin binding peptides and uses thereof

1 ... 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 ... 3163